Caldwell Sutter Capital, Inc. Immunic, Inc. Transaction History
Caldwell Sutter Capital, Inc.
- $218 Billion
- Q2 2025
A detailed history of Caldwell Sutter Capital, Inc. transactions in Immunic, Inc. stock. As of the latest transaction made, Caldwell Sutter Capital, Inc. holds 5 shares of IMUX stock, worth $4. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5
Previous 5
-0.0%
Holding current value
$4
Previous $5,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IMUX
# of Institutions
71Shares Held
47MCall Options Held
1.14MPut Options Held
130K-
Bvf Inc San Francisco, CA8.9MShares$8.72 Million0.43% of portfolio
-
Abrdn PLC8.24MShares$8.08 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$7.15 Million0.66% of portfolio
-
Avidity Partners Management LP Dallas, TX4.45MShares$4.37 Million1.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.93MShares$3.85 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $30M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...